Regeneron (REGN) Tops Q3 EPS by 132c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $735.20 +0.05%
EPS Growth %: +35.2%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
TAYD, PKE, More
EPS Growth %: +35.2%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q3 EPS of $11.14, $1.32 better than the analyst estimate of $9.82. Revenue for the quarter came in at $2.94 billion versus the consensus estimate of $2.94 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Integra LifeSciences stock tumbles after cutting 2026 outlook
- Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
